New Jersey – Aug 11, 2022: Freyr, one of the largest, global, Regulatory-focused solutions and services companies, announces the implementation of its flagship submission tracking software, Freyr SUBMIT Track, for a leading US-based, top 20 pharma company. The move is to replace the customer’s legacy technology and to avoid performance issues.
Freyr implemented Freyr SUBMIT TRACK V3.0.0 to plan and track global regions’ submissions (SLP, LCM, and DLP). Freyr SUBMIT TRACK is a lightweight, browser-based software that tracks dossiers, submissions to Health Authorities queries, and tasks. The software enables organizations to customize the dashboard for tracking dossier, submission, and task status. In addition, it also enhances submission management and tracking experience with automatic email alerts and reports generation with rich dashboards and reporting modules.
“Freyr always focuses on eliminating the challenges and en-routing towards future advancement of technology. Having worked upon those critical observations, we have always ensured to deliver the best in the industry. We are excited to have the opportunity to understand what our customers are looking for, thus ensuring the successful implementation of our flagship product submission tracking. We are certain to prove Freyr’s capability in meeting the complex demands of the global Regulatory landscape. We would take a moment to cherish this accomplishment of successful enterprise-level SUBMIT Track implementation,” said Rajiv Rangan, Co-CEO, Freyr.
Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, supporting Large, Medium, and Small size global Life Sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain, ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post-approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions. Freyr is also expanding its footprints into other key areas like Pharmacovigilance.
Headquartered in New Jersey, USA, Freyr has regional offices across the UK, Germany, France, Switzerland, UAE, Canada, Mexico, Singapore, Malaysia, South Africa, Slovenia, Sri Lanka, Australia, Poland, China, Japan, and a Global Delivery Center in Hyderabad, India.
- 1000+ global clients and growing
- 1300+ in-house Regulatory experts
- 950+ in-country Regulatory affiliates across 120+ countries
- ISO 9001 Certified for strong process and quality management
- ISO 27001 Certified for information security management, state-of-the-art infrastructure